WHO ON LOW-DOSE ORAL INTERFERON-ALPHA FOR AIDS

被引：0
|
作者：
不详
机构：
来源：
LANCET | 1990年 / 336卷 / 8720期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：935 / 935
页数：1
相关论文
共 50 条
  • [31] Low-dose interferon alpha treatment in essential thrombocythemia
    Berte, R
    Vallisa, D
    Ferrari, B
    Civardi, G
    Sbolli, G
    Cavanna, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 56 (1-2) : 104 - 105
  • [32] RAPID DETECTION OF IMMUNOREACTIVE INTERFERON-ALPHA IN AIDS
    ABBOTT, SR
    BUIMOVICIKLEIN, E
    COOPER, LZ
    LANGE, M
    BRIGGS, M
    WELLER, IVD
    LANCET, 1984, 1 (8376): : 564 - 564
  • [33] 3 YEARS CONTINUOUS LOW-DOSE INTERFERON-ALPHA TREATMENT OF HAIRY-CELL LEUKEMIA - EVALUATION OF RESPONSE AND MAINTENANCE DOSE
    GOLDMANN, B
    SONNEN, R
    KUSE, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (03) : 177 - 178
  • [34] 3 YEARS CONTINUOUS LOW-DOSE INTERFERON-ALPHA TREATMENT OF HAIRY-CELL LEUKEMIA - EVALUATION OF RESPONSE AND MAINTENANCE DOSE
    NIELSEN, B
    BRAIDE, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (04) : 174 - 179
  • [35] TREATMENT OF RECURRENT COMMON WARTS WITH ONE LOW-DOSE OF INTRALESIONAL NATURAL HUMAN-LEUKOCYTE INTERFERON-ALPHA
    PUEYO, S
    CRISCUOLO, M
    DAVIDOVICH, C
    ZORZOPULOS, J
    PESCE, A
    DIAZ, A
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1990, 4 (02): : 47 - 50
  • [36] INTERFERON-ALPHA PLUS LOW-DOSE CYTOSINE-ARABINOSIDE IN ADVANCED PHASE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
    FERRAJOLI, A
    LIBERATI, AM
    CARICCHI, P
    DONTI, E
    MORRA, E
    LAZZARINO, M
    BETTI, AR
    BERNASCONI, P
    SAGLIO, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 55 (03) : 184 - 188
  • [37] Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: A phase II clinical trial
    Ship, JA
    Fox, PC
    Michalek, JE
    Cummins, MJ
    Richards, AB
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (08): : 943 - 951
  • [38] Phase II clinical trial of low-dose interleukin-2, interferon-alpha, and low-dose tegafur uracil therapy for advanced renal cell cancer.
    Kato, Tomoyuki
    Iwamura, Masatsugu
    Fujita, Tetsuo
    Saito, Seiichi
    Ohshiro, Yoshinori
    Imai, Tomoyuki
    Kawata, Nozomu
    Tomita, Yoshihiko
    Sejima, Takehiro
    Kishida, Takeshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF LOW-DOSE ORAL INTERFERON-ALPHA IN HIV-1 ANTIBODY POSITIVE PATIENTS
    HULTON, MR
    LEVIN, DL
    FREEDMAN, LS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (11): : 1084 - 1090
  • [40] Low-dose oral interferon inhibits virally induced myocarditis
    Lawson, CM
    Beilharz, MW
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 429 - 429
12345